Zobrazeno 1 - 8
of 8
pro vyhledávání: '"María Paz Valverde Merino"'
Autor:
Ángel Carracedo Álvarez, María Paz Valverde Merino, Elena López Aspiroz, Salvador Enrique Cabrera Figueroa
Publikováno v:
Clinical drug investigation. 39(11)
Antiretroviral therapy has changed the history of HIV infection from a lethal disease to a chronic infection, with the emergence of long-term adverse effects. Herein we present a case of a heavily treated HIV-infected man in whom antiretroviral toxic
Autor:
Alfonso Domínguez-Gil Hurlé, María Jesús Hernández Arroyo, María Paz Valverde Merino, Salvador Cabrera Figueroa
Publikováno v:
Personalized medicine. 13(2)
The pharmacological treatment of HIV is complex and varies considerably among patients, as does the response of patients to therapy, requiring treatment plans that are closely tailored to individual needs. Pharmacists can take an active role in indiv
Autor:
María Paz Valverde Merino, Alicia Iglesias Gómez, Salvador Cabrera Figueroa, Alfonso Domínguez-Gil Hurlé, Elena López Aspiroz
Publikováno v:
Clinical Drug Investigation. 35:61-66
Cytochrome P450 (CYP) 3A4 has been considered to be the most important enzyme system for metabolism of lopinavir/ritonavir (LPV/r), a widely used HIV protease inhibitor (PI) recommended during pregnancy. Herein we present a clinical case of a pregnan
Autor:
María Paz Valverde Merino, Elena López Aspiroz, Salvador Cabrera Figueroa, Angel Carracedo, Miguel Cordero Sánchez, Dolores Santos Buelga, María José García Sánchez, Alfonso Domínguez-Gil Hurlé
Publikováno v:
Personalized Medicine. 11:693-704
Aim: This study aims to develop a population pharmacokinetic/pharmacogenetic model for lopinavir/ritonavir (LPV/r) in European HIV-infected patients. Materials & methods: A total of 693 LPV/r plasma concentrations were assessed and 15 single-nucleoti
Safety of the Combined Use of Praziquantel and Albendazole in the Treatment of Human Hydatid Disease
Autor:
Miguel Cordero-Sánchez, Ignacio Novo-Veleiro, Lucía Alvela-Suárez, Ángela Romero-Alegría, Javier Pardo-Lledias, María Paz Valverde-Merino, Moncef Belhassen-García, Luis Pérez del Villar, Virginia Velasco-Tirado
Publikováno v:
The American Journal of Tropical Medicine and Hygiene. 90:819-822
There is still no well-established consensus about the clinical management of hydatidosis. Currently, surgery continues to be the first therapeutic option, although treatment with anti-parasitic drugs is indicated as an adjuvant to surgery to decreas
Autor:
María Paz Valverde Merino, Miguel Cordero Sánchez, Almudena Sánchez Martín, Alicia Iglesias Gómez, Alfonso Domínguez-Gil Hurlé, Salvador Cabrera Figueroa
Publikováno v:
Clinical Drug Investigation. 30:405-411
A 48-year-old Caucasian male patient presented with severe adverse drug events (ADEs) while being treated with a standard dose (600 mg/day) of efavirenz. The patient's clinical course was favourable; however, he also described intense nightmares, cra
Autor:
Belén García-Berrocal, José Manuel González-Buitrago, Miguel Cordero Sánchez, Almudena Sánchez Martín, Maria Victoria Hernández, Carmen Bustos Tovar, María Paz Valverde Merino, María Isidoro-García, Aurelio Fuertes Martín, Salvador Cabrera Figueroa, Alicia Iglesias Gómez
Publikováno v:
Pharmacogenomics. 15(7)
Aim: Antiretroviral treatment implies a high cost to the healthcare system. The aim of this study was to evaluate the clinical and economic impact of efavirenz (EFV) dose adjustment by monitoring plasma concentrations and pharmacogenetic analysis of
Autor:
María Jesús Hernández Arroyo, Alfonso Domínguez-Gil Hurlé, Rosa Sepúlveda Correa, María Paz Valverde Merino, Salvador Cabrera Figueroa, Alicia Iglesias Gómez
Publikováno v:
Patient preference and adherence
María Jesús Hernández Arroyo,1 Salvador Enrique Cabrera Figueroa,2 Rosa Sepúlveda Correa,3 María de la Paz Valverde Merino,1 Alicia Iglesias Gómez,4 Alfonso Domínguez-Gil Hurlé5 On behalf of the Tormes Team 1Pharmacy Service, University Hospi